Related Experiment Videos
Polymethacrylic acid: induction of lymphocytosis and tissue distribution
Abstract:
Polmethacrylic acid (PMAA) induces up to a three-fold increase in the lymphocyte population of peripheral blood in rats, goats and calves after intravenous administration. Other routes of administration are less effective. A maximum lymphocytosis is achieved after 3 hr with all doses in excess of 30 mg PMAA/kg body weight; over the next few hours the lymphocyte level declines to normal. Granulocytes increase steadily for the first 7 hr before declining. Multiple doses of PMAA 2 hr apart failed to maintain or significantly alter the lymphocytosis. PMAA was labelled with 125I and 14C, and was traced to various sites in the rat. The greatest accumulation of radioactivity was in the spleen, lungs, liver, kidney, adrenals and mesenteric lymph nodes (with 14C-PMAA). The accumulation appeared more specific for spleen and lymph nodes since there was only a small loss of activity following removal of blood by whole body perfusion. This supports previous findings indicating that these two tissues play a major role in the development of lymphocytosis. Accumulation in the bone marrow may be indicative of stem cell mobilization. The results are discussed in terms of the lymphocytosis-inducing mechanism and the site of action of PMAA and the possible clinical application to ECIB therapy is considered.
Insights
Polymethacrylic acid (PMAA) significantly increases lymphocyte counts in peripheral blood across multiple species via intravenous administration. This immune response is localized primarily to the spleen and lymph nodes, suggesting a key role in lymphocytosis.
Area of Science:
- Immunology
- Pharmacology
Background:
- Polymethacrylic acid (PMAA) is known to affect immune cell populations.
- Understanding the specific effects and mechanisms of PMAA on lymphocytes is crucial for potential therapeutic applications.
Purpose of the Study:
- To investigate the lymphocytosis-inducing effects of polymethacrylic acid (PMAA) in various animal models.
- To determine the optimal administration route, dosage, and timing for PMAA-induced lymphocytosis.
- To identify the primary sites of PMAA accumulation and its role in the immune response.
Main Methods:
- Intravenous administration of PMAA to rats, goats, and calves.
- Dose-response and time-course studies to assess lymphocytosis.
- Administration of radiolabeled PMAA (125I and 14C) to rats to track tissue distribution.
- Whole-body perfusion to differentiate blood-borne from tissue-bound radioactivity.
Main Results:
- Intravenous PMAA administration induced a three-fold increase in lymphocytes in rats, goats, and calves.
- Maximum lymphocytosis occurred at 3 hours post-administration with doses exceeding 30 mg/kg.
- Significant accumulation of radiolabeled PMAA was observed in the spleen, lungs, liver, kidney, adrenals, and mesenteric lymph nodes, with higher specificity for spleen and lymph nodes.
Conclusions:
- PMAA effectively induces lymphocytosis, particularly when administered intravenously.
- The spleen and lymph nodes are key sites for PMAA action in lymphocytosis.
- PMAA's distribution suggests potential for stem cell mobilization and clinical applications, such as in ECIB therapy.